Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?

Cyclin-dependent kinases (CDK) control the cell cycle and play a crucial role in oncogenesis. Pharmacologic inhibition of CDK has contributed to the recent clinical approval of dual CDK4/6 inhibitors for the treatment of breast and small cell lung cancer. While the anticancer cell effects of CDK inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Riess, Christin, Irmscher, Nina, Salewski, Inken, Strüder, Daniel, Classen, Carl-Friedrich, Große-Thie, Christina, Junghanss, Christian, Maletzki, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Non-Thematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897202/
https://www.ncbi.nlm.nih.gov/pubmed/33161487
http://dx.doi.org/10.1007/s10555-020-09940-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897202/
https://www.ncbi.nlm.nih.gov/pubmed/33161487
http://dx.doi.org/10.1007/s10555-020-09940-4

Ejemplares similares